Search

Sofenib Tablet — Sorafenib TosylateGeneric NameSorafenib Tosylate Strength200 mg Dosage FormTablet ManufacturerRenata Limited Therapeutic ClassTargeted Cancer TherapyIndicationsHepatocellular Carcinoma: Sofenib is indicated for the treatment of patients with unresectable hepatocellular c..

DescriptionSorafenib is a kinase inhibitor that decreases tumor cell proliferation in vitro. Sorafenib was shown to inhibit multiple intracellular (CRAF, BRAF, and mutant BRAF) and cell surface kinases (KIT, FLT-3, RET, VEGFR-1, VEGFR-2, VEGFR-3, and PDGFR-ß). Several of these kinases are thought to..